- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04564625
Relationships Between Vitamin D and Orthopedic Trauma
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
INTRODUCTION 1.1. Background Vitamin D is an essential hormone involved in bone metabolism, bone mineral density maintenance, and bone health. Vitamin D deficiency is putatively linked to poor pediatric orthopedic outcomes [1]. Further, the risk of low vitamin D associated fractures may be greater in minority pediatric populations [2]. In adults, utility of vitamin D alleles as a biomarker for bone density and fracture risk has been debated for over 10 years [3-5]. Peak bone density is achieved at 25 years old; however, most orthopedic trauma patients less than 25 years of age present with substantial vitamin D deficiencies.
1.2. Aim(s)
- Identify the prevalence of vitamin D deficiency in young trauma patients with fractures.
- Describe the merits of vitamin D supplementation in healing and long-term outcomes ≤25 year old trauma patients with fractures.
1.3. Rationale for the study Occurrence of stress and low energy mechanism fractures within a population at peak bone density is troubling and suggestive of underlying pathology. Understanding how to combat vitamin D deficiency, and improve outcomes, is essential in the development of comprehensive and preventative trauma care.
1.4. Hypothesis 1.4.1. Primary Hypothesis Patients aged ≤25yrs old with fractures will have low vitamin-D levels.
OBJECTIVES AND STUDY OUTCOME MEASURES 2.1. Study Objectives 2.1.1. Primary Objective Determine the frequency of vitamin D deficiency in fracture patients aged less than 25 years old.
2.1.2. Secondary Objective Report the long-term (one year) outcomes for fracture healing relative to baseline and therapeutic vitamin D levels.
2.2. Study Outcome Measures 2.2.1. Primary Outcome Vitamin D levels at the time of the index injury through one year post-operative follow up.
2.2.2. Secondary Outcomes Patient demographics (age, sex, ethnicity), injury characteristics, lab values, rate of nonunion (i.e., failure of a fractured bone to heal), admit information, discharge disposition, payer type, and mortality.
- STUDY DESIGN All patients between 18 and 25 years treated for fractures at Methodist Dallas Medical Center (MDMC) with an index admission vitamin D assessment will be enrolled. This study will consider any patients with an index admission occurring between February 2016 and February 2020. No changes to care or intervention will occur and this study will be conducted completely via chart review. The aim is to identify 100 subjects with a one-year follow-up appointment for their injury to determine the rate of nonunion and vitamin D levels. As patients receive vitamin D supplementation as standard of care if index values are low, impact will be assessed through relative deficiency and clinical outcomes. Data collected from subjects without need for supplementation may be used to generate a threshold. Patient demographics will be considered as practice suggests minority patients may be disproportionally affected. The plan to complete the data collection and analysis by February 2021.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Methodist Health System Clinical Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients must be >18 years old and ≤25 years old
- Patients must have any fracture requiring follow-up
- Patients must have received vitamin-D assessment
Exclusion Criteria:
- Patients aged >25yrs
- Prisoners
- Pregnant
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Fracture and Vitamin D assessment
All patients between 18 and 25 years treated for fractures at Methodist Dallas Medical Center (MDMC) with an index admission vitamin D assessment will be enrolled.
This study will consider any patients with an index admission occurring between February 2016 and February 2020.
No changes to care or intervention will occur and this study will be conducted completely via chart review.
The aim is to identify 100 subjects with a one-year follow-up appointment for their injury to determine the rate of nonunion and vitamin D levels.
As patients receive vitamin D supplementation as standard of care if index values are low, impact will be assessed through relative deficiency and clinical outcomes.
Data collected from subjects without need for supplementation may be used to generate a threshold.
|
index admission vitamin D assessment
rate of nonunion (i.e., failure of a fractured bone to heal)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vitamin D levels at the time of the index injury through one year post-operative follow up.
Time Frame: February 2016 and February 2020
|
Vitamin D levels at the time of the index injury through one year post-operative follow up.
|
February 2016 and February 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient demographics
Time Frame: February 2016 and February 2020
|
age, sex, ethnicity
|
February 2016 and February 2020
|
injury characteristics
Time Frame: February 2016 and February 2020
|
injury characteristics
|
February 2016 and February 2020
|
rate of nonunion
Time Frame: February 2016 and February 2020
|
failure of a fractured bone to heal
|
February 2016 and February 2020
|
admit information
Time Frame: February 2016 and February 2020
|
admit information
|
February 2016 and February 2020
|
discharge disposition
Time Frame: February 2016 and February 2020
|
discharge disposition
|
February 2016 and February 2020
|
payer type
Time Frame: February 2016 and February 2020
|
payer type
|
February 2016 and February 2020
|
mortality
Time Frame: February 2016 and February 2020
|
mortality
|
February 2016 and February 2020
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Edgar Araiza, MD, Methodist
Publications and helpful links
General Publications
- Horan MP, Williams K, Hughes D. The Role of Vitamin D in Pediatric Orthopedics. Orthop Clin North Am. 2019 Apr;50(2):181-191. doi: 10.1016/j.ocl.2018.10.002.
- Ramirez N, Ortiz-Fullana JL, Arciniegas N, Fullana A, Valentin P, Orengo JC, Iriarte I, Carlo S. Vitamin D levels and fracture risk among Hispanic children. Eur J Orthop Surg Traumatol. 2019 Apr;29(3):531-536. doi: 10.1007/s00590-018-2315-7. Epub 2018 Oct 13.
- McClean E, Archbold GP, Taggart HM. Do the COL1A1 and Taq 1 vitamin D receptor polymorphisms have a role in identifying individuals at risk of developing osteoporosis? Ulster Med J. 2003 May;72(1):26-33.
- Lorentzon M, Lorentzon R, Nordstrom P. Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy caucasian men: a cross-sectional and longitudinal study. J Clin Endocrinol Metab. 2000 Apr;85(4):1666-70. doi: 10.1210/jcem.85.4.6566.
- Ensrud KE, Stone K, Cauley JA, White C, Zmuda JM, Nguyen TV, Eisman JA, Cummings SR. Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999 Oct;14(10):1637-45. doi: 10.1359/jbmr.1999.14.10.1637.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 005.TRA.2020.D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractures, Bone
-
Lawson Health Research InstituteCompleted
-
AO Innovation Translation CenterRecruitingLong Bone FracturesUnited States, Canada, Australia, Ghana, Chile, China, Germany, India, Pakistan, Venezuela, Spain, Croatia, Greece
-
University Hospital, Clermont-FerrandRecruiting
-
Centre Hospitalier Universitaire Saint PierreRecruiting
-
McMaster UniversityMcMaster Surgical AssociatesCompleted
-
University of UtahCompletedBone Strength | Stress Fractures | Bone Geometry | Biomechanical ChangesUnited States
-
IlluminOss Medical, Inc.CompletedHumerus Fracture Metastatic Bone DiseaseUnited States
-
University of British ColumbiaCompleted
-
Novo Nordisk A/SCompletedBone Fracture | Tibia FracturesIsrael, Germany, Finland, Hungary, Spain, South Africa, Norway, France, Poland
-
Carlos A Acosta-OlivoCompletedRadius Fractures | Bone Fractures | Closed Fractures
Clinical Trials on Vitamin D Assessment
-
Ghamra Military HospitalAl-Azhar UniversityCompleted
-
National Opinion Research CenterCenters for Disease Control and Prevention; Emory HealthcareCompleted
-
Arkansas Children's Hospital Research InstituteUniversity of ArkansasUnknownEosinophilic EsophagitisUnited States
-
PfizerTerminated
-
Umeå UniversityRegion SkaneCompleted
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolCompletedYellow Fever | Viral Infection | Endoplasmic Reticulum StressSingapore
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Khon Kaen UniversityNot yet recruiting
-
Nutrition Institute, SloveniaSlovenian Research Agency; Higher School of Applied Sciences (VIST); Valens Int...CompletedVitamin D DeficiencySlovenia
-
USDA, Western Human Nutrition Research CenterCompletedVitamin D DeficiencyUnited States